Vls Generics And Biosimilars Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2022.
2022 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Vls Generics And Biosimilars Private Limited

Vls Generics And Biosimilars Private Limited, a active private limited company, was established on 11 April 2022 in Hyderabad, Telangana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24290TG2022PTC161465. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.20 M.

Its leadership includes Sivaji Gorinta (Director), Venkata Balarama Krishnam Raju Gokaraju (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plotno 113 Flatno. 101,10 By Istahomes Syn 43/P, Kavuri Hills, Guttala Begumpet, Hyderabad, Telangana, 500033.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290TG2022PTC161465

  • Registration Number

    161465

  • Incorporation Date

    11 April 2022

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 3 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Vls Generics And Biosimilars Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Vls Generics And Biosimilars Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Vls Generics And Biosimilars Private Limited?
Current Directors
Name Designation Appointment Date Status
Sivaji Gorinta Director 11 Apr 2022 Current
Venkata Balarama Krishnam Raju Gokaraju Director 11 Apr 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vls Generics And Biosimilars.

Enhance accessibility to Vls Generics And Biosimilars's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Vls Generics And Biosimilars revenue growth over time
Vls Generics And Biosimilars profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vls Generics And Biosimilars?

Unlock access to Vls Generics And Biosimilars's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Vls Generics And Biosimilars?

Vls Generics And Biosimilars has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vls Generics And Biosimilars, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vls Generics And Biosimilars's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vls Generics And Biosimilars
Recent Activity within the Organization
  • Annual General Meeting

    Vls Generics And Biosimilars Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Vls Generics And Biosimilars Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Director Appointment

    The activity Sivaji Gorinta was appointed as a Director was appointed as a Director on 11 Apr 2022 & has been associated with this company since 3 years 10 months . was completed.

  • Director Appointment

    The activity Venkata Balarama Krishnam Raju Gokaraju was appointed as a Director was appointed as a Director on 11 Apr 2022 & has been associated with this company since 3 years 10 months . was completed.

  • Company Incorporation

    Vls Generics And Biosimilars Private Limited was registered on 11 Apr 2022 with Roc Hyderabad & aged 3 years 10 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Vls Generics And Biosimilars Private Limited?

The CIN of Vls Generics And Biosimilars Private Limited is U24290TG2022PTC161465.

Where is Vls Generics And Biosimilars Private Limited headquartered?

Vls Generics And Biosimilars Private Limited is headquartered at Plotno 113 Flatno. 101,10 By Istahomes Syn 43/P, Kavuri Hills, Guttala Begumpet, Hyderabad, Telangana, 500033.

When was Vls Generics And Biosimilars Private Limited incorporated?

Vls Generics And Biosimilars Private Limited was incorporated on 11 April 2022.

Who are the current directors of Vls Generics And Biosimilars Private Limited?

The current directors of Vls Generics And Biosimilars Private Limited are

What is the primary industry of Vls Generics And Biosimilars Private Limited?

The primary industry of Vls Generics And Biosimilars Private Limited is Chemicals.

Is Vls Generics And Biosimilars Private Limited a listed company?

Vls Generics And Biosimilars Private Limited is unlisted.

What is the capital structure of Vls Generics And Biosimilars Private Limited?

The authorized capital of Vls Generics And Biosimilars Private Limited is ₹0.50 M, and the paid-up capital is ₹0.20 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available